Proctalgia secondary to rectal arteriovenous malformation and inferior mesenteric vein stenosis in a patient post liver transplant

Autor: N Rutledge, Jeffrey W. McCann, Gerard M. Healy, F Gondal, D D Houlihan

Publikováno v: CVIR Endovascular, Vol 4, Iss 1, Pp 1-4 (2021)
CVIR Endovascular

Background Chronic proctalgia can have a major impact upon quality of life. There are many potential aetiologies however, in some patients no cause can be identified. Case presentation We present a patient post liver transplant with intractable proct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2540850ba995d5e8ac9d98a1cee6dc8c
https://doi.org/10.1186/s42155-020-00196-1

Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit

Autor: D. D. Houlihan, Ian A. Rowe, David Mutimer

Publikováno v: Alimentary pharmacologytherapeutics. 36(7)

Summary Background Protease inhibitors have improved sustained virological response (SVR) rates for subjects with genotype 1 hepatitis C virus infection (HCV). There is however uncertainty regarding how, and in whom, these agents should be used. In p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31121e8cf49d6151f56b6cd8829808e9
https://pubmed.ncbi.nlm.nih.gov/22906241

Hepatitis B related hepatocellular carcinoma. Screening, screening and more screening.

Autor: Sopena-Falco J, McCormick A, MacNicholas R, Houlihan D, Bourke M, Feeney E

Publikováno v: Irish medical journal [Ir Med J] 2023 Apr 20; Vol. 116 (4), pp. 756. Date of Electronic Publication: 2023 Apr 20.

Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.

Autor: Kieran JA; Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland. jkieran@tcd.ie.; National Centre for Pharmacoeconomics, St. James Hospital, Dublin, Ireland. jkieran@tcd.ie., Norris S; Department of Hepatology, St. James Hospital, Dublin, Ireland. snorris@stjames.ie.; School of Medicine, Trinity College Dublin, Dublin, Ireland. snorris@stjames.ie., O'Leary A; National Centre for Pharmacoeconomics, St. James Hospital, Dublin, Ireland. aoleary@stjames.ie.; School of Pharmacy, Royal College of Surgeons of Ireland, Dublin, Ireland. aoleary@stjames.ie., Walsh C; MACSI and Health Research Institute, University of Limerick, Limerick, Ireland. cathal.walsh@ul.ie., Merriman R; Liver Unit, St. Vincent's University Hospital, Dublin, Ireland. raphael.merriman@ucsf.edu., Houlihan D; Liver Unit, St. Vincent's University Hospital, Dublin, Ireland. diarmaidhoulihan@hotmail.com., McCormick PA; Liver Unit, St. Vincent's University Hospital, Dublin, Ireland. aiden.mccormick@svuh.ie., McKiernan S; Department of Hepatology, St. James Hospital, Dublin, Ireland. smckiernan@stjames.ie.; School of Medicine, Trinity College Dublin, Dublin, Ireland. smckiernan@stjames.ie., Bergin C; Department of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin, Ireland. cbergin@stjames.ie.; School of Medicine, Trinity College Dublin, Dublin, Ireland. cbergin@stjames.ie., Barry M; Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland. mbarry@stjames.ie.; National Centre for Pharmacoeconomics, St. James Hospital, Dublin, Ireland. mbarry@stjames.ie.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2015 Oct 26; Vol. 15, pp. 471. Date of Electronic Publication: 2015 Oct 26.

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

Autor: Gane E; Auckland Hospital Clinical Studies Unit, Auckland, New Zealand., Kershenobich D, Seguin-Devaux C, Kristian P, Aho I, Dalgard O, Shestakova I, Nymadawa P, Blach S, Acharya S, Anand AC, Andersson MI, Arendt V, Arkkila P, Baatarkhuu O, Barclay K, Ben-Ari Z, Bergin C, Bessone F, Blokhina N, Brunton CR, Choudhuri G, Chulanov V, Cisneros L, Croes EA, Dahgwahdorj YA, Daruich JR, Dashdorj NR, Davaadorj D, de Knegt RJ, de Vree M, Gadano AC, Gower E, Halota W, Hatzakis A, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kostrzewska K, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Mossong J, Norris S, Nurmukhametova E, Oltman M, Oyunbileg J, Oyunsuren Ts, Papatheodoridis G, Pimenov N, Prins M, Puri P, Radke S, Rakhmanova A, Razavi H, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanchez Avila JF, Sanduijav R, Saraswat V, Schréter I, Shah SR, Shevaldin A, Shibolet O, Silva MO, Sokolov S, Sonderup M, Souliotis K, Spearman CW, Staub T, Stedman C, Strebkova EA, Struck D, Sypsa V, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuckerman E, Zuure FR, Prabdial-Sing N, Flisiak R, Estes C

Publikováno v: Journal of viral hepatitis [J Viral Hepat] 2015 Jan; Vol. 22 Suppl 1, pp. 46-73.